LGALS3 and androgen insensitivity syndrome: However, the serum galectin-3 levels of AIS patients in the PSCI cohort and non-PSCI cohort were (8.4 ± 2.3) ng/mL and (4.9 ± 1.6) ng/mL, respectively.